PharmacyCodes



Triamcinolona [Inn-Spanish] en es it fr

Categoria

Triamcinolona [Inn-Spanish] Marchi, Triamcinolona [Inn-Spanish] Analoghi

Triamcinolona [Inn-Spanish] Marchi miscela

  • Aristoform R Crm 0.1% (Clioquinol + Triamcinolone Acetonide)
  • Derma-4 Ont (Neomycin Sulfate + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Kenacomb Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Mild Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Mild Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Mecomb Crm 0.1% (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Oribiotic Ointment (Bacitracin + Lidocaine + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Panolog Cream (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Panolog Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Ratio-Triacomb Regular Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Solvaderm Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Theraderm Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Viaderm Kc Crm (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Viaderm Kc Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)

    • Triamcinolona [Inn-Spanish] Formula chimica

    C21H27FO6

    Triamcinolona [Inn-Spanish] RX link

    http://www.rxlist.com/cgi/generic/triamaer.htm

    Triamcinolona [Inn-Spanish] FDA foglio

    Triamcinolona_[Inn-Spanish] FDA

    Triamcinolona [Inn-Spanish] DMS (foglio di materiale di sicurezza)

    Triamcinolona_[Inn-Spanish] MSDS

    Triamcinolona [Inn-Spanish] Sintesi di riferimento

    Fried et al. J. Am. Chem .. Soc. 80, 2338 (1958)

    Triamcinolona [Inn-Spanish] Peso molecolare

    394.434 g/mol

    Triamcinolona [Inn-Spanish] Temperatura di fusione

    274 - 278 (dec) oC

    Triamcinolona [Inn-Spanish] H2O Solubilita

    80 mg / L

    Triamcinolona [Inn-Spanish] Stato

    Solid

    Triamcinolona [Inn-Spanish] LogP

    0.329

    Triamcinolona [Inn-Spanish] Forme di dosaggio

    Crema; liquidi; dosato (aerosol); unguento, Incolla; sospensione; Sciroppo; Tablet

    Triamcinolona [Inn-Spanish] Indicazione

    Per il trattamento di perenne e rinite allergica stagionale.

    Triamcinolona [Inn-Spanish] Farmacologia

    Triamcinolone ed i suoi derivati sono glucocorticoidi sintetici che vengono utilizzati per le loro proprietà antinfiammatorie e immunosoppressive.

    Triamcinolona [Inn-Spanish] Assorbimento

    Un rapido assorbimento dopo somministrazione orale

    Triamcinolona [Inn-Spanish] Tossicita

    LD50 => 500mg/kg (nei ratti)

    Triamcinolona [Inn-Spanish] Informazioni paziente

    Patients being treated with Azmacort Inhalation Aerosol should receive the following information and instructions. This information is intended to aid them in the safe and effective use of this medication. It is not a complete disclosure of all possible adverse or intended effects.

    Patients should use Azmacort Inhalation Aerosol at regular intervals as directed. Results of clinical trials indicate that significant improvement in asthma may occur by 1 week, but maximum benefit may not be achieved for 2 weeks or more. The patient should not increase the prescribed dosage but should contact the physician if symptoms do not improve or if the condition worsens.

    In clinical studies and post-marketing experience with Azmacort Inhalation Aerosol, local infections of the oropharynx with Candida albicans have occurred. When such an infection develops, it should be treated with appropriate local or systemic (i.e., oral antifungal) therapy while remaining on treatment with Azmacort Inhalation Aerosol. However, at times therapy with Azmacort Inhalation Aerosol may need to be interrupted.

    Patients should be instructed to track their use of Azmacort Inhalation Aerosol and to dispose of the canister after 240 actuations since reliable dose delivery cannot be assured after 240 doses.

    Patients who are on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chickenpox or measles and if exposed, to obtain medical advice.

    Triamcinolona [Inn-Spanish] Atto interessato organismi

    Gli esseri umani e altri mammiferi